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The Ministry of Health and Social Services (MOHSS) of Namibia has been conducting HIV surveillance among pregnant 
women attending ANC every other year since 1992. However, population-based HIV surveillance for the very first time 
was attained with the completion of the 2013 National Demographic and Health Survey. 
In 2012, the Ministry embarked upon the first evaluation to assess the utility of PMTCT program data as the basis for HIV 
surveillance among pregnant women. This exercise comprises of an assessment of the quality and completeness of 
routine PMTCT data; to compare HIV test results and prevalence estimates from ANC HSS and PMTCT data; to assess the 
quality of PMTCT HIV testing and quality assurance methods. 
The results showed high levels of agreement between NHSS and PMTCT HIV test results. However the levels of percent 
agreement were slightly below what is set as a general standard by WHO/UNAIDS for the use of PMTCT program data 
alone for HIV Sentinel Surveillance. 
The assessment further revealed that Namibia may be approaching readiness to transition to a PMTCT-program-data­
based system of HSS. However, Implementing and standardizing the proper measures to address and rectify site-level 
sources of discrepancies in results would adequately prepare Namibia to phase out the current practice of conducting 
UAT-based ANC HSS in order to transition to utilizing routinely collected PMTCT program data for HIV surveillance 
purposes. 
The MOHSS is thankful for the political commitment that the Government of Namibia has shown in giving the fight 
against HIV and AIDS a top priority in all its undertakings. It is this support and commitment that create a favorable 
eMironment enabling the Ministry to achieve all its accomplishments in the fight against HIV and AIDS to date. We will 
be failing in our duty if we don't acknowledge the tremendous contributions made by our partners. The MOHSS 
appreciates the support of our development and bilateral partners, including the United States Centers for Disease 
Control and Prevention, the technical assistance of the University of California San Francisco, and the staff and 
participants who were integral to the success of this evaluation. 
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Mr A.ndrew Ndishishi IBIA ~ 
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The Permanent Secretary 
EXECUTIVE SUMMARY 

This evaluation was used to assess the utility of Prevention-of-Mother-to-Child HIV Transmission (PMTCT) program data 
for HIV surveillance in place of Antenatal Clinic (ANC) based surveillance in Namibia. 
ANC-based HIV sentinel surveillance (ANC HSS) is the basis for monitoring national trends in HIV infection in many 
countries, through HIV testing of blood samples collected during routine ANC visits by pregnant women. With PMTCT 
programs rapidly expanding, PMTCT data may increasingly be used for surveillance purposes. PMTCT programs target 
the same population of pregnant women as in ANC-based surveillance and they often collect similar information. At the 
WHO/AFRO HIV Surveillance meeting in July 2009 it was established that the strengthening of PMTCT programmes for 
surveillance purposes should be a priority surveillance activity. There is, however, little known about the comparability 
of ANC-based PMTCT data to ANC based sentinel surveillance data in most countries. It is not known how HIV test 
results and prevalence would compare between ANC HSS and PMTCT program data. The quality of site PMTCT 
individual-level data and HIV testing quality assurance methods are often uncertain. 
In Namibia, the Ministry of Health and Social Services (MOHSS) conducts ANC HSS every other year, using standardized 
methodology recommended by the World Health Organization (WHO). Unlinked, anonymous HIV testing is completed 
on blood samples collected for routine syphilis screening from pregnant women attending ANC clinics. ANC HSS among 
pregnant women began in Namibia in 1992 at 8 sites. The number of sites continued to increase since 1994 to improve 
national representativeness. Most recently, the 2014 sentinel survey covered all 35 main sites in the country, including 
an additional 98 satellite sites. 
The objective of this evaluation was to assess the utility of PMTCT program data as the basis for HIV surveillance among 
pregnant women in Namibia, including: to assess the quality and completeness of routine PMTCT data; to compare HIV 
test results and prevalence estimates from ANC HSS and PMTCT data; to assess the quality of PMTCT HIV testing and 
quality assurance methods. The evaluation achieved these objectives by prospectively capturing information about 
PMTCT HIV testing uptake and results on the ANC HSS form; gathering information on site PMTCT HIV testing, recording 
and patient flow characteristics; retrospectively examining PMTCT records from before and during the ANC HSS period; 
and assessing adherence to HIV rapid testing quality assurance measures put in place by the MOHSS and implemented 
by the National Institute of Pathology (NIP). Data collected contained no personal identifiers. 
Results of this assessment highlighted that a transition from UAT-based to PMTCT-based HIV sentinel surveillance is 
feasible in Namibia. High levels of agreement between NHSS and PMTCT HIV test results, minimum selection bias, 
excellent HCT availability and uptake through the PMTCT program at HSS sites, and high data quality indicate that 
Namibia may be approaching readiness to transition to a PMTCT-program-data-based system of HSS. Although national 
level NHSS and PMTCT-program-data prevalence estimates are virtually identical, levels of percent agreement are 
slightly below what would be required for the use of PMTCT program data alone for HSS and trend-analysis which all 
require accurate sub-national inputs. Potential site-level sources of results disagreement, including quality of PMTCT 
rapid testing and data, must be identified and corrected and compliance with existing RT-QA standards needs to be 
strengthened. Implementing and standardizing the proper measures to address and rectify site-level sources of 
discrepancies in results would adequately prepare Namibia to phase out the current practice of conducting UAT-based 
ANC HSS in order to transition to utilizing routinely collected PMTCT program data for HIV surveillance purposes. 
1. BACKGROUND 

Information about trends in the prevalence of human immunodeficiency virus (HIV) infection in the general population is 
necessary for countries to monitor the course of their epidemics and to measure the effectiveness of, and plan for, 
evidence-based prevention, care and treatment (PCT) interventions. In most countries of sub-Saharan Africa (SSA) with 
generalized or mixed epidemics, national HIV estimates and projections are based on annual or biennial antenatal care 
(ANC)-based HIV sentinel sero-surveillance (ANC-HSS) (1). ANC clinics provide an accessible cross-section of healthy, 
sexually active women in the general population and data from ANC-HSS are considered to be representative of the 
underlying population. ANC-HSS are typically conducted through unlinked anonymous testing (UAT) of pregnant women, 
following UNAIDSjWorld Health Organization (WHO) guidance on sentinel surveys among pregnant women (1, 2), in 
which leftover blood from specimens collected for routine syphilis testing are sent to reference laboratories and tested 
for HIV using third or fourth generation enzyme linked immunosorbent assay (ELISA) tests. 
Prevention-of-mother-to-child-transmission (PMTCT) programs have scaled-up rapidly in sub-Saharan Africa during the 
past decade, with many countries attaining high coverage (3). PMTCT programs are integrated into routine ANC services 
and therefore access the same sample of women accessed through ANC-HSS (4). Standard PMTCT-program reporting 
tools include the same data required for routine HIV sentinel surveillance (HSS) among pregnant women receiving 
antenatal care, including the HIV test result, age, gravidity, clinic location and place of residence of each woman 
receiving ANCjPMTCT services . Therefore, it may be possible to conduct HIV surveillance among pregnant women by 
utilizing routinely collected PMTCT program data. 
There are several potential advantages to replacing ANC- HSS with a system of PMTCT-based surveillance. The expansion 
of access to treatment services has highlighted ethical issues inherent in UAT-based ANC-HSS, given that this 
methodology does not allow pregnant women to consent to HIV testing or to receive their HIV test results, and be 
referred to available treatment services. PMTCT-based surveillance provides prevention services by ensuring that 
sampled women are tested for HIV, receive their HIV test results, and are referred to the appropriate treatment 
services. Other advantages include reducing the substantial workload and financial costs associated with conducting 
ANC HSS, fostering a programmatic culture of using routine program data for surveillance and improving PMTCT 
program monitoring and evaluation for improved service delivery (5). 
There are some limitations to using PMTCT data for HIV surveillance: PMTCT HIV testing services may be inaccessible; 
inconsistent due to stock-outs of HIV test kits; or of poor quality at some or many sites (4). Quality of PMTCT program 
data may vary by site or over time. Selection bias of PMTCT HIV testing data may arise if testing acceptance varies by 
patient sub-groups. Each of these factors could affect the accuracy and representativeness of HIV prevalence estimates 
and therefore limit the utility of PMTCT program for routine surveillance. 
The WHO/AFRO Technical Network on HIV / AIDS and STI Surveillance recommended in 2009 that the strengthening of 
PMTCT programmes for surveillance purposes should be a priority surveillance activity (6). Currently, no country in sub­
Saharan Africa (SSA) has replaced ANC-HSS with PMTCT-based surveillance . Several countries have conducted 
assessments to explore the potential for transition. Published results from studies conducted in SSA prior to 2010 
provide mixed evidence in support of using PMTCT program data for routine surveillance. Studies in Botswana (2005­
2007) (4), Cameroon (2003) (7), and Uganda (2001-2003, 2004-2005) (8, 9) reported that PMTCT data could be 
adequate for surveillance purposes in these countries. However, studies in Kenya (2003, 2005, 2006, 2008, 2010) (10 ­
13), Burkina Faso (1996) (14), Zimbabwe (2004) (15), Uganda (2002-2003, 2004) (16), Ethiopia (2005) (12), and Rwanda 
(2007) (17) suggest that PMTCT program data for routine HIV surveillance in these countries would be biased . Common 
factors contributing to bias that were reported by these studies include: differences in age-specific estimates between 
the two data sources; low uptake of PMTCT HIV testing; differences in estimates when PMTCT HIV testing uptake was 
low or when PMTCT services had been recently introduced at the ANC; poor PMTCT data quality; site-level differences in 
HIV prevalence estimates between ANC HSS and PMTCT data. 
Until recently, no standardized methodology for assessing the utility of PMTCT program data for routine surveillance had 
been available. In July 2013, the WHO/UNAIOS Working Group on Global HIV/AIOS and STI Surveillance collaboratively 
released, Guidelines for assessing the utility of data from prevention of mother-to-child transmission (5). Briefly, the 
guidelines advise that countries may consider replacing ANC-HSS with PMTCT-program based-surveillance if the 
following criteria are met: 
1. 	 Agreement between ANC HSS and PMTCT HIV test results is high. 
2. 	 The magnitude of selection bias inherent in PMTCT HIV testing data compared to ANC HSS data is limited. 
3. 	 The proportion of ANC HSS sites that provide PMTCT HIV testing services is universal. 
4. 	 The quality of routinely collected PMTCT program data at ANC HSS sites, including the minimum dataset of 
variables for surveillance is high. 
S. 	 Quality Assurance (QA) practices for PMTCT HIV testing at ANC HSS sites are robust. 
This study was a collaborative effort between the Ministry of Health and Social Services (MOHSS) of the Government of 
the Republic of Namibia (GRN) and the United States Centers for Disease Control and Prevention (CDC), with assistance 
from the Namibia Institute of Pathology (NIP), which aimed to assess the utility of PMTCT program data for routine HIV 
surveillance among pregnant women receiving ANC in Namibia (18). This study was implemented in accordance with the 
methodological guidance from WHO/UNAIOS (5) . 
2. METHODS 
2.1 Overview 0/ANC-HSS and PMTCT program in Namibia 
ANC-HSS in Namibia is conducted biennially according to UNAIDSjWorld Health Organization (WHO) 2003 on 
surveillance among pregnant women and utilizes an UAT approach without informed consent or disclosure of results to 
(2, 19). However, all ANC patients inclusive of those who participated in the survey are offered the 
opportunity to know their HIV status through the HIV and testing routine test. In Namibia, ANC-based 
sentinel surveillance has been conducted biennially since 1992. This survey is called the National HIV Sentinel Survey 
(NHSS). The survey began with sites in 1992 and has since expanded to include main and satellite sites from all 35 
health districts in order to nationally-representative HIV prevalence estimates among pregnant women. 
WHO gUidelines for conducting HIV sentinel surveillance among pregnant women recommend an UAT approach for data 
collection. In this approach individual survey forms (ISF) are used to collect socio-demographic information from eligible 
women. All required data for the survey are extracted from the ANC records (ANC & and 
logged onto the which includes the a bar coded sticker with unique 
identification code, date of ANC visit, district abbreviation and site number, type of facility, woman's age, gravidity, place 
of whether or not a is on ART, and whether or not the patient is counseled for PMTCT. Once routine 
for other purposes syphilis) is an aliquot (0.5 to 2.0ml) of leftover sera is obtained and 
transferred to a sterile plastic tube or cryovial and labeled with the survey code that corresponds to that found on the 
form with the socio-demographic data. After testing, the left over specimen is unlinked by removal of all personal 
identifiers. This specimen is then used for HIV the results of which are included in the ANC HSS. 
For Namibia's NHSS, blood are in ethylenediaminetetraacetic acid (EDTA) anticoagulant tubes for 
routine syphilis testing via rapid plasma reagent (RPR) and the leftover volume is sent to the NIP laboratory in 
Windhoek for HIV antibody testing using an enzyme-linked immunosorbent assay (ELISA) (19). The Roche Architect HIV 
agjab Combi Assay test is an ELISA used to detect HIV antibodies (HIV-1/2) (sensitivity 100% CI: 98.4­
100%], 99.5% [95% CI: 97.2 100%]) (Roche Diagnostics, Manheim, Germany) (20). All NHSS specimens that 
test positive are confirmed using a second ELISA, the COBAS e601 Analyzer Assay (sensitivity % [95% CI: %], specificity % 
[95% CI: %]) (21). Discordant results are classified as HIV-negative. 
The PMTCT program in Namibia has scaled up rapidly since its introduction in 2002 and it was available in over 90% of 
health facilities nationwide by 2012 (22). According to routine program data, approximately 90% women 
who delivered at ANC clinics knew their HIV status at time of delivery and the of HIV 
women that received ART in ANC or labor and delivery settings reached 95%. PMTCT services are into routine 
ANC services in Namibia. PMTCT services are currently available at all main and satellites sites that were included in the 
2012 NHSS. All women sampled in the NHSS are offered PMTCT services on the same visit when they are for 
the NHSS. PMTCT services in Namibia include provider-initiated HIV testing and counseling (PITC), which is performed by 
the ANC nurse or an HIV counselor during the first ANC visit. PMTCT HIV testing and counseling (HCT) follows 
the national HIV algorithm: each woman receives parallel rapid with the Determine HIV-1/2 
test (Abbott Abbott Park, Illinois, USA: sensitivity 100.0% 95.5- 100.0%], specificity 99.4% [CI: 96.7­
100.0%]) and the Uni-Gold HIV (Trinity Biotech, Dublin, Ireland: sensitivity 100.0% [CI: 95.5-100.0%], specificity 100.0% 
[CI: 97.9-100.0%]); discordant results are confirmed with a tiebreaker test using the Clearview Complete HIV 1/2 assay 
(Chembio Systems, Inc., Medford, NY, USA: sensitivity 99.7% [CI: 98.9%-100%], specificity 99.9% [CI: 99.6%­
100%]) (20). If initial or tie-breaking test results confirm a result before 29 weeks into the pregnancy, women 
are advised to be re-tested from 36 weeks of gestation. 
To ensure quality control, standardized HIV rapid test logbooks are used at all ANC/PMTCT sites. Internal quality 
assurance is conducted weekly by facility supervisors. External quality assurance through retesting is performed, 
requiring that all facilities submit 5.0% (l.e./ione-in-20") of all blood each month to the NIP National Reference 
for External quality assurance through proficiency testing is performed quarterly at all dual 
ANC/PMTCT sites where HIV rapid testing services are available. Quarterly site assessments are conducted by regional 
quality assurance officers from NIP. During site assessments, quality assurance officers review the logbooks and 
systematically review HIV rapid testing procedures and site using a standardized checklist. 
2.2 Methods of the assessment 
The 2012 NHSS individual survey forms (ISF) were modified to collect data about routine HeT received through the 
PMTCT program including the PMTCT HIV test results- from each NHSS participant at the time of NHSS The 
NHSS was conducted from March to August 2012 at 3S main-sites, representing each of the country's 3S health districts, 
which were supplemented by 98 satellite sites (totaling 130 sites). At the end of the survey, NHSS ELISA and PMTCT 
rapid HCT results were compared for each NHSS participant who had both results available. 
2.3 Assessment of testing agreement between NHSS and PMTCT program 
Individual level data were used to calculate positive percent agreement (PPA) and negative percent agreement (NPA) of 
NHSS and PMTCT HIV testing in order to measure concurrence between the two testing methods. NHSS and PMTCT HIV 
prevalence, PPA and NPA between NHSS and PMTCT HCT HIV test results were calculated at the site level. Using the HSS 
test result as the "Gold Standard," PPA was defined as the percentage of women testing HIV positive by NHSS ELISA who 
were correctly classified as HIV positive by the PMTCT rapid test, while I'JPA was defined as the percentage of women 
testing HIV negative by HSS who were correctly classified as HIV negative by the PMTCT rapid test. 
2.4 Assessment of selection bias in PMTCT program 
PMTCT HCT access and PMTCT HCT uptake were measured to ensure that all sites participating in the assessment were 
offered HCT services and to assess the level to which pregnant women were accessing HCT services. The magnitude of 
selection bias inherent in PMTCT HIV testing data compared to ANC HSS data was also measured to deduce potential 
associations between acceptance of PMTCT HIV testing and likelihood of being HIV-positive or of known HIV-positive 
status. Selection bias is defined as the percent relative change from the total NHSS HIV prevalence among participants 
who do and do not receive PMTCT HCT, to the NHSS HIV prevalence among HSS participants who do receive PMTCT HCT. 
The formula for calculating selection bias is as follows: 
HIV prevalence among pregnant) (HIV p1'evalence among all ) 
women sampled by ANC 55 who - pregnant women sampled 
( 
consent to PMTCT HIV testing by ANC 55 
Percent bias = x 100
H IV prevalence among all pregnant women sampled by ANC 55 
2.5 ANC facility site assessment 
The site assessment was conducted by a study staff member to collect quantitative and qualitative data on basic 
features and procedures of the co-located ANC HSS and PMTCT site . The aim of this questionnaire was to identify 
programmatic or service-delivery gaps that could pose challenges to a PMTCT-based system of HIV surveillance in 
Namibia (e .g. variations in registers used for data collection, accuracy of programmatic and data collection procedures, 
frequency of rapid testing kit stock outs, etc.). The questionnaire inquired about services offered and data collection 
procedures at each facility during that were in place from March to September of 2013, approximately one year after 
the implementation of the 2012 NHSS. 
Increasingly, HIV positive women who know their positive status are having repeated pregnancies. Because women who 
are already known to be HIV positives would be included in an ANC HSSPMTCT data would falsely underestimate HIV 
prevalence if HIV information on these women is not collected in PMTCT records. The site assessment examined 
whether known HIV positive women are tested and how and where the status of known HIV positive women is 
recorded. 
2.6 PMTCT program data quality assessment (DQA) 
A retrospective, PMTCT program data quality assessment (DQA) was performed. Demographic and clinical data of 
pregnant women that were recorded during routine ANC/PMTCT first-visits were assessed from facility based PMTCT 




receipt of HIV pre-test counseling, HIV test, and HIV post-test counseling; 
HIV test result, and; 
receipt of ARV prophylaxis for PMTCT and CD4 test among HIV positive women only. 
Any non-missing or legal value of a variable recorded in the register was classified as complete and/or valid, respectively. 
The predetermined evaluation standard for both completeness and validity were set by a national level technical 
working group at 90%, which is consistent with the "Guidelines for On-Site Data Verification and Rapid Services Quality 
Assessment used by The Global Fund to Fight AIDS, Tuberculosis and Malaria" (23). The DQA were performed from 
March to May 2012 and again from March to May 2013 to assess whether data quality varied between NHSS and non­
NHSS years. 
2.7 PMTCT HIV rapid testing QA assessment 
The WHO/UNAIDS guidance advises that assessments of the utility PMTCT program data for ANC-HSS include the 
administration of an HIV rapid testing quality assurance (QA)"checklist" to assess PMTCT HIV rapid testing QA procedure 
in place at each ANC-HSS site (5). However, because Namibia has a fully functioning HIV rapid testing QA system, the 
WHO/UNAIDS recommended checklist was not used. NIP oversees HIV rapid testing QA at public health facilities in 
Namibia and administers two QA tests on a regular basis to all sites that provide HIV rapid testing. The 5% or "one-in-20" 
retest requires all sites to send a blood sample for every 20th client who receives a rapid testing to an NIP laboratory for 
confirmatory testing each month. Proficiency panel tests are blind panels that are sent to all sites on a quarterly basis for 
testing and the sites must test the samples and return their results to NIP . NIP staff also visit rapid test sites to perform 
supervisory visits and qualitatively evaluate the sites' adherence to rapid testing conditions and protocols using a 
standardized questionnaire, which is based on the HIV rapid testing standard operating procedures specified in the 
MOHSS National Guidelines on HIV Counseling and Testing (24). Data collected from each element of this HIV rapid 
testing QA system is stored in a national-level NIP HIV rapid testing QA database. 
2.8 Data analysis 
All analyses were performed using Stata/SE 12.1 software (StataCorp . 2011. Stata Statistical Software: Release 12.1 
College Station, TX: StataCorp LP.). 
2.8.1 HIV prevalence estimates 
Pooled and site level HIV prevalence estimates by NHSS and PMTCT were calculated. Tests for site level differences 
between NHSS and PMTCT HIV prevalence estimates were performed using the Chi-square two-sample test of 
proportions, with P values ~ 0.05 considered statistically significant. All statistical tests were two-sided. 
2.8.2 Testing agreement and selection bias 
PPA and NPA were calculated at the site level. The calculations for PPA and NPA are identical to those of sensitivity and 
specificity, respectively (Table 1). However, because the NHSS HIV testing algorithm has imperfect performance 
characteristics (i .e. < 100% sensitivity and specificity) it should not be considered a reference standard; hence the terms 
positive percent agreement and negative percent agreement were used. These measures are used in this context 
because they provide the most accurate picture of the interface between the two testing algorithms and where 
disagreement may be occurring. NPA and PPA calculations were performed including and excluding known positives, in 
order to assess the effect of this sub-group on overall testing agreement. Logistic regression was used to estimate the 
participant level odds for negative disagreement (i.e. PMTCT result positive and NHSS result negative) and positive 
disagreement (i .e. PMTCT result negative and NHSS result positive) at the individual participant level, adjusted for age, 
gravida, urban/rural clinic location, and site sample size. Stata's Usvyset" command was used to declare a survey design 
for the dataset with the NHSS site indicated as the primary sampling unit and the u svy" prefix was used during the 
logistic regression analysis so that each NHSS site was treated as a separate cluster and each woman was given equal 
statistical weight in all analyses. 
Table 1: Calculation of positive percent agreement and 
negative percent agreement of ANC 55 and PMTCT HIV 
testing 
HIV+ a b a+b 
HIV- e d c+d 
Total a+c b+d a + b + c +d 
* Non-reference standard 
a 
Positive percent agreement = 100 x-­
a+c 
d 
Negative percent agreement = 100 x-­
b+d 
Selection bias was also calculated at the site-level. Pooled percentages, as well as the median and interquartile range 
(IQR), of the site-level percentages, were calculated at the national-level. General assessment standards set by the WHO 
for using PMTCT data for surveillance are as follows: pooled PPA > 97.9, pooled NPA > 99.7, pooled PMTCT HCT uptake ~ 
90%, and pooled selection-bias :=; +/- 10%. 
2.8.3 ANCfacility site assessment 
The total number and percentage of facilities complying with different programmatic and data collection procedures 
between March to September of 2013 (22) were calculated using the site assessment questionnaire. 
2.8.4 PMTCT DQA 
Median percent completeness and validity of select variables and interquartile ranges (IQRs) were assessed for each site, 
as well as pooled for all sites participating in the 2012 NHSS. 
2.8.5 HIV rapid testing quality assurance 
Data from the NIP RT QA database were abstracted and the total number and percentage of NHSS sites meeting the 
following criteria was tallied: 
1. 	 Submitted at least one "one-in-20" retest sample during NHSS; 
2. 	 Submitted the required number of "one-in-20" retest samples during NHSS 
3. 	 Received a passing score (based on nationally set standards) on all "one-in-20" retest samples submitted during 
the NHSS; 
4. 	 Submitted at least one proficiency panel test during the NHSS; 
5. 	 Submitted the required number of proficiency panel tests during survey period (i.e. one proficiency panel every 
3 months of the NHSS implementation); 
6. 	 Received a passing score on all proficiency panel samples submitted during NHSS. 
Passing scores are evaluated according to pre-determined standards set by NIP in accordance with standard operating 
procedures specified in the MOHSS National Guidelines on HIV Counseling and Testing (24). 
2.9 Human subjects consideration 
The 2012 NHSS protocol, which included the protocol for the assessment of routine PMTCT program data for ANC-HSS, 
was approved by the Research Committee of the MOHSS and the Associate Director of Science of the Centers for Global 
Health of the US CDC. Informed consent was not collected from women from whom data was collected and analyzed as 
this was a retrospective study using routine program data and personally de-identified data from the 2012 NHSS. 
3. RESULTS 
3.1 HIV testing agreement and selection bias 
A total of 7,996 pregnant women participated in the 2012 NHSS, 68.2% and 50.3% of which were prima-gravida and 
sampled from rural clinics, respectively (Table 2). Median participant age was 25 years. Overall, 18.2% of women tested 
HIV positive through NHSS. Women with previous known positive (KP) status (n= 860) composed 10.8% of the total 
sample and 59.2% of the 1,452 women that tested HIV positive (data not shown) . 
Table 2. Sample characteristics of women included in the 2012 NHSS 
Variable 	 Result 
Total women sampled, II 	 7,966 
Age, median (lQR) years 	 25 (21 - 31) 
Age 15-24, % (C/) 	 47.0 (45.2 - 48.7) 
Prima-gravida, % (C/) 	 68.2 (66.2 - 70.2) 
Sampled at rural site, % (el) 	 50.3 (37.0 - 63.6) 
Sampled at site with < 200 participants, % (C/) 	 81.2 (67.0 - 95.4) 
Tested ositive through NHSS, % (C/) 	 18.2 (15.7 - 20.7) 
A total of 99.0% of women who participated in the 2012 NHSS received HCT services through the PMTCT program at the 
time of sampling and the site level median (IQR) of receipt of PMTCT HCT was 100% (98.5-100%)(Table 3) . Pooled 
prevalence estimated by PMTCT HIV rapid testing was 18.2% and site level comparisons between PMTCT and NHSS 
prevalence estimates showed no significant differences between NHSS and PMTCT prevalence estimates. Pooled 
selection bias was 0.25% and the site level median (IQR) was 0.00% (0.00 - 0.38%). Pooled PPA and NPA were 95.3% 
and 99.1% respectively. Site level median (IQR) for PPA and NPA was 96.9% (93.1 - 98.2%) and 99.1% (98.7 - 100%) 
respectively. Assessment criteria for PMTCT HCT uptake, selection bias, PPA, and NPA, respectively, were met at 100%, 
100%, 37.1% and 37.1% of the 35 main sites and at 96.9%, 96.2%, 88.5%, and 95.4% of the 130 satellite sites, 
respectively (Table 4). PMTCT HCT was available at all sites. 
Being sampled at a "large" site (i.e. ~ 200 participants) was associated with increased odds for positive results 
disagreement [AOR : 2.16 (95% CI: 0.99 - 4.71), P=0.05], while previously known positive HIV status was associated with 
increased odds for negative results disagreement [AOR: 9.62 (95% CI: 4.96 - 18.66), P <.001] (Table 5) . 
Table 3. HIV prevalence estimates, receipt of HIV counseling and testing, selection bias and percent agreement, overall and by site. 
PMTCT ,IlV prevalence NHSS HIV provolcnee P-val. PMTCT HIV testine Percent bias PPA (95% (I) NPA (95% (I) 
(SS\\;; el) (95% (I) uptake (95% (I) 
Overall (pooled) 18.0 (--) 18.2 (--) (--) 99.0 (--) 0.25 95.3 ( .. ) 99.1 ( . • ) 
By site 
Andara 19.2 (14.2-24.1) 19.1 (14.3 - 23 .9) 0.97 100(- .) 0.0 93.9 (S7.1 . 100) 99.5 (98.5 - 100) 
Aranos 11.2 (5.6 - 16.8) 11.2 (5.6 - 16.8) 96.9 (93.9 - 99.9) -4.1 100(--) 99.1 (97 .2 -100) 
Eenhana 14 (9.7- lS.3) 15 (10.6 - 19.4) 0.75 98.S (97.5 . 100) 1.2 84.2 (72.4-96.0) 9S.6 (97.0 . 100) 
Engela 20.6 (15.9 - 25.2) 19.3 (14.7 - 23.9) 0.7 100 (- . ) 0.0 98.2 (94 .6 - 100) 9S.3 (96.6 - 99.9) 
Gobabis 10.4 (6.3 . 14.6) 9.9 (6 - 13.8) 0.86 95 (92.2 -97.9) 5.2 100 (._) 100 (._) 
Grootfontein 15.4 (10.6-20.3) 15.9 (11 - 20.8) 0.89 100 (_.) 0.0 91.2 (81.4 -100) 98 .9 (97.3 - 100) 
Karasburg 14.6 (9.S· 19.3) 14.9 (10.2 - 19.6) 0.93 97.395.2- 99.4) -0.3 96.9 (90.7- 100) 100 (.-) 
Katima Mulilo 38 (33 - 43) 38 (33 - 43) 0.95 98.4 (97.1- 99 .7) 0.2 9S.6 (96.5 - 100) 99.1 (97.9 -100) 
Katutura 16.4 (12.1 . 20.6) 14A (lOA - 18A) 0.5 99.3 (98.4 - 100) 0.7 95.2 (88.7- 100) 97.2 (95.1- 99.3) 
Keetmanshoop 11.2 (6.6-15.9) 10.6 (6.1-15.1) 0.85 100 (._) 0.0 94.4 (83.5-100) 98.1 (96.0-100) 
Khorixas 10.2 (5.9 - 14.4) 12.4 (7.8 -17.1) 0.48 100 (._) 0.0 79.2 (62.5 - 100) 99.4 (98.2 . 100) 
Luderitz 21.7 (16.5 - 26.9) 22 (16.8 - 27. 2) 0.93 99 .6 (98.8 - 100) 004 98.1 (94.5-100) 100 (.-) 
Mariental 14.6 (9.7-19.6) 13.5 (8.8 - 18.2) 0.74 98 (96.1-99.9) 2.0 100 (-.) 98.S (97.2- 100) 
Nankudu 13.6 (8.4 - 18.S) 13.1 (804 - 17.8) 0.88 95 (91.9 - 98.0) 5.3 100 (._) 100 (_.) 
Nyangana 22.6 (16.4 - 28.8) 22.0 (16.1- 27.9) 0.89 100 (--) 0.0 92.7 (84.6- 100) 99.3 (97.8 - 100) 
Okahandja 16.3 (11 .8 - 20S) 16.3 (11.9 - 20.8) 0.98 100 (.-) 0.0 97.7 (93 .1- 100) 99.5 (9S.7 . 100) 
Okahao 18.5 (13 - 24.1) 19.3 (13.6 - 24.9) 0.85 100 (-.) 0.0 97.2 (91.7-100) 100(--) 
Okakarara 7.7 (2.8 - 12.5) 9.9 (4.6 - 15.3) 0.55 96 .7 (93.5 - 99.9) -5.2 81.8 (57.7 - 100) 100 (.-) 
Okongo 20.9 (15.S· 25.9) 20.8 (15.8 - 25.8) 0.98 99.2 (98.1 . 100) -1.1 98.0 (94.2 - 100) 99.0 (97.6- 100) 
Omaruru l1.S (7.1 - 16A) 11.8 (7.1- 16.4) 100 (-.) 0.0 100(--) 100 (--) 
Onandjokwe 25.7 (20.7- 30.6) 25.9 (20.8 - 31) 0.95 95.3 (92.9 - 97.7) 0.8 97.3 (93.6 - 100) 99.1 (97.8-100) 
Opuwo 9.1 (4.4- 13.S) 9.8 (4.9 -14.7) 0.83 100 (_.) 0.0 92.9 (78.7-100) 100 (-.) 
Oshakati 22 (17.4 - 26.6) 22.3 (17 .7-27.0) 0.92 100(--) 0.0 94.2 (88.6 - 100) 98.S (97.3 - 100) 
Oshikuku 24 (19.1- 29) 24.7 (19.7 - 29.6) 0.86 99.7 (99.0 - 100) 0.4 97.2 (93.3 - 100) 100 (--) 
Otjiwarongo 16.5 (11.8-21.3) 16.9 (12.2 - 21.7) 0.9 100(--) 0.0 92.5 (84.2-100) 99.0 (97.6-100) 
Outapi lS.7 (13. 7 - 23.6) 17.6 (12.9 - 22.3) 0.76 100 (_.) 0.0 77.8 (65.4 - 100) 99.5 (98.4 - 100) 
Outjo 12.S (8.3 . 17.3) 12.8 (8.3 - 17.3) 100 (.-) 0.0 96.3 (89.0 - 100) 96.9 (94.5-99.4) 
Rehoboth 9.8 (3.3 - 16.2) 9.8 (3 .3 - 16.2) 100 (--) 0.0 87.5 (62.6 . 100) 9S.6 (96.0 - 100) 
Rundu 24.5 (19.6-29.4) 25.2 (20.2 - 30.1) 0.85 100(· -) 0.0 97.2 (93.4 - 100) 98.2 (96.4-99.9) 
Swakopmund 14.8 (10.3 - 19.2) 14.5 (10 - 18.9) 0.93 100(· -) 0.0 94.3 (86.4 - 100) 9S.6 (96.9 - 100) 
Tsandi 23.5 (18.8-28.3) 23.5 (18.S - 2S.3) 0.96 99.4 (98.5 - 100.3) 0.7 95.8 (91.0 . 100) 9S.7 (97 .2 - 100) 
Tsumeb 18.2 (13.9 - 22.6) 19.2 (14.7 - 23 .7) 0.75 99.7 (99.06 . 100.3) -lA 96.4 (91.5 - 100) 99.6 (9S.S· 100) 
Usakos 12.7 (7.7 -17.7) 12.2 (7.4 - 17) 0.89 95 .6 (92.6-98.6) -0.1 100(· -) 100 (-.) 
Walvis Bay lS.4 (13.7-23.1) 17.2 (1l.6 - 21.S) 0.72 99.6 (98.9-100.4) OA 97.8 (93.4 . 100) 98.1 (96.3 - 99.9) 
Windhoek Central 17.2 (12.6 - 21.8) 9.6 (4.S - 1404) 0.99 100 (._) 0.0 100(-·) 100(- -) 
Site level median (IQR) 16.3 (12 .0 - 20.8) 15.9 (12.3 - 20.4) (--) 100 (98.5 - 100) 0.00 (0 .00 ­ 0.38) 96.9 (93.1 - 98.2) 99 .1 (98.7 . 100) 
Table 4. Main and satellite sites that satisfied the assessment standards for receipt of PMTCT HIV testing, percent bias and percent agreement. 
Main sites (N=35) that satisfied Main and sentinel sites (N=130) that 
Variable assessment standard, % ' satisfied assessment standard, % 
Women received PMTCT HCT (i.e. PMTCT testing "uptake") 100 96.9 
Percent bias 100 96.2 
Negative percent agreement 37.1 88.5 
Positive percent agreement 37.1 95.4 
a. Assessment standards are as follows : NPA > 99.7, PPA > 97.9, pooled PMTCT HCT up toke ~ 90%, and pooled selection-bias., +/-10%. 

Table S. Adjusted odds ratios for PMTCT and NHSS HIV test results disagreement among participants enrolled in the NHSS 2012 

AOR (95% ell for negative AOR (95% (I) for positive 
Independent variable disagreement' P val. disagreement · P val. 
1.20 (0.65 - 2.24) 0.55 1.00 (0.44 - 2.24) 0.99 Age 15-24 years ' 
0.99 (0.55· 1.78) 0.97 0.81 (0.35 - 1.84) 0.61Prima-gravida d 
NA NA 9.62 (4.96 - 18.66) <.001Previously known positive HIV status' 
0.94 (0.44 - 1.99) 0.34 1.32 (0.68 - 2.57) Urban site location f 0.42 
1.36 (0.66 • 2.82) Site sample ~200 g 2.16 (0.99·4.71) 0.05 0.42 
a. Participant's PMTCT result = pasitive and HSS result = negative, b. Participant's PMTCT result = negative and HSS result =positive, c. Ref. group: age 25-49 years, d. 
Ref. group: multi-gravida, Ref. group: not previously KP. KP variable not included in model to predict negative disagreement because ref. group perfectly predicts 
failure, Ref. group: rural site location, Ref. group: site with sample <200 
3.3 ANC facility site assessment · 
Of the 130 ANC facilities that partiCipated in the 2012 ANC HSS, 127 had individuals available to respond to the facility 
assessment questionnaire (Table 6). Results of the questionnaire indicate that the majority of facilities were using the 
most current version of the ANC/PMTCT register and the Monthly Summary Form (MSF) (86% and 78%, respectively). 
while 96% offer HIV rapid testing services. Of the facilities offering HIV RT services, 100% were using the correct HIV RT 
algorithm. In the 12 months preceding the survey, approximately 28% of facilities were unable to provide HIV RT at least 
once due to HIV RT kit stock outs, while approximately 14% were unable to provide HIV RT because the certified tester 
was sick or on leave . Approximately 93% of facilities correctly defined someone who is "known positive" (KP) HIV status 
and 95% of facilities knew to provide HIV test to women who claim they are KP but have no documentation of their 
status. Almost all (99%) facilities provide syphilis testing as part of routine ANC services and the majority reported using 
the telephone or community tracing as a means to return syphilis test results to patients. 
Table 6. Results of the dual ANC HSS and PMTCT facility site assessment results, 2013 a 
Variable 
HIV rapid testing is routinely available at site 
Correct HIV RT algorithm used at site 
One or more community counselors perform HIV RT at site 
:s 30 minutes average waiting time for clients to receive HIV RT results at site 
No instances of HIV RT stock outs during past 12 months at site 
No instan ces of certified rapid tester staff during past 12 months at site 
Current version of ANC/PMTCT register in use at site ., 
Current version of ANC/PMTCT monthly summary form in use at site ' 
Correctly entering HIV test result into the ANC register b 
Staff correctly defined "previously known HIV positive" women at site 
HIV rapid testing is offered to women who self-report at previously known positive without documentation 
at site 
Syphilis testing is routinely available during ANC first visit at site 
Syphilis test results returned from lab in less than one week at site 
Use community tracing to return syphilis test results to clients at site 















a. Mast current versions af ANC/ PMTCT register and MSF were distributed November, 2011, b. HIV rapid tester enters result into ANC passport, woman gives passport 
to nurse when she returns to the consultation room and nurse enters result inta ANC register 
3.2 PMTCT DQA 
The median site-level percentage of PMTCT program data completeness and validity exceeded 90.0% during both review 
periods for the following variables: age, gravidity, trimester, receipt of HIV pre-test counseling, receipt of HIV test; HIV 
test result; receipt of HIV post-test counseling (Table 7). The receipt of CD4 and ARV for PMTCT variables were less than 
90.0% complete or valid during both review periods. 
Table 7. Data quality assessment of completeness and validity of variables in facility-based PMTCT registers. 
Mar - May 2012 Mar - Mav 2013 
SIte med,an % (IQR) Site median % (IQR) 
Variable Complete Valid Complete Valid 
Age 100 (100 - 100) 100 (100 -100) 100 (100 - 100) 100 (100 - 100) 
Gravidity 100 (100 - 100) 100 (100 - 100) 100 (100 - 100) 100 (100 - 100) 
Trimester 94.9 (98.6 - 86.3) 95.0 (98.6 - 86.3) 94.0 (97.9 - 84.8) 94 .8 (98.2 - 85.8) 
HIV pre-test counseling 99.4 (100 - 94 .8) 98.4 (100 - 94.4) 97.7 (100 - 91.8) 97.1 (100 - 91.6) 
Tested for HIV 97.4 (100 - 93.5) 97.3 (100 - 93.5) 95.9 (100 - 88.1) 94.7 (100 - 88.1) 
HIV result 100 (100 - 98.1) 100 (100 - 97.1) 99.5 (100 - 94 .9) 99.0 (100 - 92.4) 
HIV post-test counseling 93.2 (98.9 - 82.9) 93.0 (98.9 - 82.9) 91.9 (96.2 - 81.8) 90.3 (95.0 - 82.5) 
Received ARV for PMTCT 83.3 (100 - 42.9) 83 .3 (100 - 42.9) 87.5 (100 - 64.5) 86.7 (100 - 50.0) 
Received CD4 test 41.0 (68.6 - 41.0) 31.8 (66.7 - 0) 38.1 (77.8 - 0) 38.1 (77.8 - 0) 
3.3 Rapid testing QA 
Of the 130 facilities included in the NHSS, 92 (71.0%) submitted at least one "one-in-20" retest samples and 105 (81.0%) 
sites submitted at least one proficiency panel test during the survey period. Of these sites, 23.0% and 79.0% submitted 
the required number of "one-in-twenty" retest and proficiency panel test samples, respectively. Among facilities that 
submitted retest and proficiency panel samples, the pass rate was 99.0% for retests and 99.0% for proficiency panels. 
Among the 92 sites with "one-in-20" re-test data available, 21 (22.9%) submitted ~4% of their samples for re-testing and 
29 (31.3%) submitted ~3% of their samples for re-testing. 
Table 9. Summary of rapid testing quality assurance procedures implemented at NHSS sites 
Variable (N) Number (%) 

Submitted at least one "one-in-20" retest sample during NHSS (N=130) 92 (71.0) 

Submitted required number of "one-in-20" retest samples during NHSS • (N=130) 21 (23.0) 
Received a passing score on all "one-in-20" retest samples submitted during NHSS b (N=92) 91 (99.0) 

Submitted at least one proficiency panel test during survey period (N=130) 105 (81.0) 

Submitted required number of proficiency panel tests during survey period' (N=130) 79 (75.0) 
Received a passing score on all proficiency panel samples submitted durin NHSS d (N=105) 78 (99.0) 
a. required number according to NH55 sample size, e.g. if 200 women were sampled at site during NH55, 10 retes t samples should be submitted for that site, b. denominator of percent 
calculation only includes sites that submitted "one-in-20" retest samples, c. required number according to number of quarters af implementation 0/ NHSS (2 quarters), i.e. all sites should have 
submitted at feast 2 proficiency pone/samples, d. denominator of percent calculation only includes sites that submitted proficiency panel samples 
4. DISCUSSION 
This study is the first to report results produced by methods recommended by the WHO/UNA/OS for assessing the utility 
of PMTCT program data for routine H/V surveillance among pregnant women receiving ANC in Namibia. According to our 
results, there is strong evidence in support of using PMTCT data for routine HSS in Namibia. 
The WHO/UNAIOS guidance stipulates that PPA or I'JPA between PMTCT and ANC-HSS results in countries with ANC-HSS 
prevalence of ~17 .0% should generally be 97.6% and 99.5%, respectively, in order to favor a transition to PMTCT-based 
HSS (5) . Agreement below those thresholds exceeds what would be expected due to statistical variability and is likely 
due to performance characteristics between the HSS or PMTCT HIV testing algorithms (5). In this study, the estimated 
PPA (95.3%) and NPA (99 .1%) were both lower than what is generally recommended by WHO/UNA/OS. PPA was higher 
than estimates produced in similar settings (26), but NPA was less robust. These results suggest that Namibia is 
approaching but has not entirely arrived at readiness to transition to a PMTCT program data-based system of routine 
HSS. Our results suggest that additional analyses designed to elucidate factors contributing to results disagreement, 
additional data quality activities and strengthening of the existing RT QA program may be required prior to a full 
transition. 
Exploratory analysis of site-level PPA and NPA suggest that excluding known positives from PPA/NPA calculations 
improves PPA but reduces NPA. The effect of KP on NPA could be an indication that HSS participants may be incorrectly 
recorded as known positive, and/or that PPA may be less than originally estimated. Further investigation is needed to 
determine the underlying effect of KPs on PPA and NPA calculations, to discern whether HSS is giving false positive 
results or whether PMTCT HIV RT is giving false negative results. Low NPA also has important programmatic implications, 
suggesting that approximately one in 100 H/V-negative women receive a false positive RT result at first ANC. Given the 
high volume of negatives, this could mean a small but substantial proportion of women may be receiving ARV for PMTCT 
under false pretext. However, analysis at the site level found RT positive results disagreement to be concentrated in few 
sites. Therefore, identification and correction of factors affecting agreement at these sites could result in improved 
overall NPA and could be in place for PMTCT surveillance data collection activities. 
The association between patient factors and results disagreement that was explored through logistic regression showed 
that; 1) women sampled at large sample sites were more likely to produce negative results disagreement, and; 2) 
women classified as previously KP were more likely to produce positive results disagreement. The first result suggests 
that client volume at an ANC clinic may adversely affect testing quality . /t is plausible that nurses performing RT in high­
volume sites may rush to complete a client's RT in order to attend to all of the clients awaiting services during an ANC­
first visit clinic, subsequently leading to human errors in reporting test results. Previous studies have reported that with 
a high volume of testing, even a small error can result in a large number of misdiagnosed cases (27) . 
The second result suggests that KP positive women may be incorrectly classified or recorded as such during the ANC first 
visit. Namibia ANC/PMTCT guidelines stipulate that women without official documentation of KP status be offered an 
HIV test (22). However, our results suggest that this gUidance may not be uniformly implemented, or that women self­
identifying as KP but without documentation may be refusing an HIV test but are, nevertheless, documented as KP by 
the nurse responsible for entering data in the PMTCT register. If known HIV-positive women are not systematically 
included in PMTCT programme data, surveillance estimates based on PMTCT data would falsely underestimate HIV 
prevalence (5). This interpretation is partially supported by further analysis indicates that excluding known HIV positive 
women from PPA and NPA calculations improves PPA from 95.3% to 99.6%, and decreases NPA from 99.1% to 88.8%. 
The extent to which self-report and documentation of previously known positive HIV status effects percent agreement 
needs to be further explored. 
HCT access and uptake through the PMTCT program in Namibia was excellent, and the introduction of bias due to 
exclusion of women who do not receive PMTCT HCT was minimal. These results strongly support transition to PMTCT 
program-based HIV surveillance and compare favorably to findings in other countries in SSA: Studies in Zimbabwe 
(2004), Cameroon (2003), and Botswana (2005-2007) all listed low HCT uptake as an obstacle to using PMTCT program 
data for HIV surveillance. Other studies have identified factors which may lead to the introduction of selection bias into 
PMTCT-based prevalence estimates (28 - 34). Pregnant women who perceive that they have an increased risk of being 
infected may be more likely to opt out of PMTCT testing, resulting in an underestimation of HIV prevalence. Other 
factors-including reluctance to test without a partner's consent, educational level, age, parity, gravidity and 
employment-have also been found to be associated with opting out of HIV testing, although the direction of bias 
introduced by these factors is unclear. Pregnant women who are not tested because they already know their HIV status 
to be positive can also contribute to selection bias, underscoring the need to consider the unique status of these women 
when conducting an assessment (5). 
The facility assessment results highlighted strengths of introducing a PMTCT program-based HSS in Namibia . Overall, 
facilities appear to comply with all proper procedures for PMTCT program services as outlined in the MOHSS PMTCT 
Guidelines (22). The high number of facilities providing on-site HIV rapid testing services and complying with 
programmatic procedures to confirm the status of known HIV-positive women are both conducive to a PMTCT-based 
system of HIV surveillance. However, the frequency of HIV RT kit stock-outs has the potential to undermine a PMTCT­
based system of HIV surveillance, thus steps need to be put in place to ensure that RT kits are procured in a timely 
manner . Additionally, changes in routine data collection tools, such as the ANC/PMTCT register and Monthly Summary 
reporting Form, could pose challenges to data collection processes if facilities do not transition to the appropriate tools 
in a timely manner. Finally, although facilities may be abiding by the correct procedures to confirm a woman's KP status, 
women with no proof of their HIV-positive status may still refuse an HIV test, thus underestimating HIV prevalence in 
that facility . 
The DQA results also support transition to PMTCT program-based HSS in Namibia. Completeness and validity of data 
elements essential to surveillance in the ANC/PMTCT registers was excellent and only data elements not essential to 
surveillance reporting were of low quality. These DQA results are considerably higher than results produced in similar 
settings. A study conducted in South Africa (2009) revealed that data collected and reported across high HIV-prevalence 
districts was neither complete nor accurate enough to track process performance or outcomes for PMTCT care (35), 
while another study in Kenya (2003) cited variances in PMTCT logbook formats and low levels of accurately reported 
data as challenges to a PMTCT-based HIV surveillance system (10). 
Nevertheless, the accuracy of data in Namibia varied between different levels of the PMTCT program data reporting 
chain, with the point of 'breakdown' in the chain occurring during data abstraction and entry from paper-based monthly 
summary forms to the electronic DHIS. Values observed in monthly summary forms were minimally divergent from 
values of "raw" data observed in the site-level PMTCT registers, whereas values obseNed in DHIS reports were greatly 
divergent from values observed in the registers. This finding has important implications for the practical application of a 
PMTCT program-based system of ANC-HSS in Namibia; namely, if HIV prevalence estimates are to be produced from 
data abstracted from routine PMTCT-program reporting tools, data cannot be abstracted from the national level DHIS 
data base until sources of data inaccuracy are identified and corrected. At present, only data abstracted directly from 
the facility based registers (at an individual level) or monthly summary forms (at an aggregate level) would be 
acceptable for producing PMTCT-based surveillance estimates. 
Namibia has established robust standards for implementing RT QA procedures at health facilities where RT is performed. 
Namibia's standards are aligned with international standards (24, 36). However, our results show that these standards 
are not uniformly implemented at all sites. According to data in the NIP RT-QA database, few sites were fully compliant 
with standardized QA protocols. The explanatory potential of PMTCT-based HIV prevalence estimates would be limited 
without assurance that all sites were implementing RT-QA in compliance with standardized guidelines. Therefore, 
proposals to transition to a PMTCT program-based system of ANC-HSS in Namibia would need to be accompanied by a 
fortification of the RT-QA system to ensure that all sites are routinely compliant with standardized protocols. 
A limitation of this study is that the quantitative (i.e. optical density ELISA values) of the NHSS results were not available 
for analysis. The raw surveillance laboratory testing data could elucidate the origin of discrepancies in the RT/ELISA 
comparison. In particular, RT false negatives may be associated with ELISA optical density (00) values that are above the 
threshold but low, suggesting possible ELISA false positive (5). Namibia may consider further testing of such specimens 
by Western blot or polymerase chain reaction (PCR) to confirm or rule out HIV infection. A second limitation of this study 
is that it was not powered to assess correlations between compliance with RT-QA protocols and PPA/NPA between 
PMTCT and ANC-HSS results . Finally, methods included in the WHO gUidelines focus on assessing PMTCT and ANC-HSS 
results agreement using the HSS result as the reference standard . Since HSS is done in a controlled laboratory 
environment with QA procedures in place, we presume these results are likely to be accurate and reliable; however we 
were not able to further investigate them to exclude HHS errors as the cause of discrepancies. 
S. CONCLUSION AND RECOMMENDATIONS 
This activity highlighted the potential strengths and challenges for a PMTCT-based HSS in Namibia . High levels of 
agreement between NHSS and PMTCT HIV test results, minimum selection bias, excellent HCT availability and uptake 
through the PMTCT program at HSS sites, and high data quality indicate that Namibia is approaching readiness to 
transition to a PMTCT-program-data-based system of HIV surveillance . Although national level NHSS and PMTCT­
program-data prevalence estimates are virtually identical, levels of percent agreement are slightly below what is set as a 
general standard by WHO/UNAIOS for the use of PMTCT program data alone for HSS, trend-analysis, and estimates, 
which all require accurate sub-national inputs. By prioritizing measures to address and rectify site-level sources of 
discrepancies, the MOHSS should be able to phase out the current practice of conducting UAT-based ANC HSS and 
transition to utilizing routinely collected PMTCT program data for HIV surveillance purposes in the near future. With this 
in mind the MOHSS and its partners should consider the following recommendations : 
Identify and correct site-level sources of results disagreement - including quality of PMTCT rapid testing and data 
and proper recording of KP pregnant women - through additional exploratory analyses, in-service trainings and 
supervisory support that focus on correct data entry and reporting procedures. 
Ensure compliance with existing RT-QA standards at all levels of PMTCT program implementation, and 
strengthen the ability of the NIP QA Unit to conduct routine QA site visits at all sites where HIV RT is available . 
Conduct routine OQA assessments to ensure that PMTCT program data sustains the high level of quality that 
was observed by this study. 
Strengthen HIS at all levels to facilitate access, quality and use of PMTCT program data. 
Prioritize the development of methodology for a PMTCT program data system of routine HSS. 
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9. APPENDICES 
Appendix A: 2012 Individual Survey Form for collection of demographic variables 
Ministry of Health and Social 
Services 
HIV ANC Sentinel Surveillance Survey 
Individual survey form 




1 Date of interview D D / M M / y y y y 
2 District abbreviation 
3 Site Number 
4 Type of facility 
l=hospita/ 2=health centre 3=c/inic 
Extract information below directly from the Ante Natal Care Passport and the ANC Register 
5 Patient age (in years) 
6 
Place of current 
locations) 
residence (town name/farm/village and not 
7 Gravidity 
8 Patient on HAART? 
1=yes 2=no 
9 Did patient receive HIV pre-test counseling? 
1=Yes 2 =No 
10 Was patient tested for HIV? 
1= Yes 2= No 
11 HIV test Result 
1=Positive, 2 =Negative 3 =Undetermined 
tested) 6=results missing 
4 =Not tested 5 =known positive (not 
12 Nurse's initials 
(Surname fol/owed by initial or given name) 
Appendix B: Assessment of the Utility PMTCT Program Data for Routine HIV Sentinel in Namibia 
COMPLETENESS-VALIDITY ASSESSMENT fORM 
# valid 
# complete 
POST TEST COUN # valid 
Appendix C: HSS/PMTCT Comparison FACILITY ASSESSMENT INTERVIEW QUESTIONAIRE 
1. NHSSS site code (XXX -##) 
~ Notes: refer to Appendix E of the SOP manual to confirm the facility's NHSS site code. 
2. Site Name 
3. Name and Job Title (e.g. Enrolled Nurse, Registered Nurse, Community Counselor) of Respondent (s) 
4. Today's date (dd/mm/yyyy) 
o [] 
5. Interviewer's (Field Team Leader) name 
6. PMTCT program at site since date (mm/yyyy) 
[]D 0 
7. Is ANC/PMTCT HIV testing performed by rapid test at this facility? 
a. Yes 
b. No 
7b. If "yes", since what date (mm/vyvy) 
8. Is the ANC/PMTCT HIV testing approach "opt-in" or "opt-out" 
o a. opt-in 
b. opt-out 
9. Versions of ANC/PMTCT Register in use 
~ Notes: field team should ask to see the ANC/PMTCT and HCT each indicated time point 
9a. Which version of the ANC/PMTCT register is in use currently? 
:11 
9b. Which version of the ANC/PMTCT register was in use from Mar. 2012 - May 2012 
10. Versions of HCT in use 
lOa. Which version of the HCT Register is in use currently? 
lOb. Which version the HCT Register was in use from Mar. 2012 - May 2012 
-7 If RAPID TESTING IS NOT PERFORMED AT THIS SKIP TO QUESTION 20 
11. What is the PMTCT HIV algorithm for on-site rapid including the screening assay, confirmatory assay, 
and tie breaker assay? 
lla. screening assays? 
a. Determine and Unigold 
D b. Determine and Clearview 
c. Unigold and Clearview 
d. other 
lIb. tie-breaker/ confirmation assay? 
a. Determine 
b. Unigold 
o c. Clearview 
d. other 
12a. Who is currently for HIV rapid TQClr1nO for ANC clients 
D a. a registered nurse 
b. always an enrolled nurse 
D c. always a community counselor 
D d. either an RN or an depending on who is available 
D e. either an RN, an or a community depending on who is available 
f. others 
12b. if "other", please specify _________ 
13. How many community counselors are currently performing testing for ANC clients at this facility? 
a. none 
D b. one 
D c. two 
d. three or more 
14a. Who was responsible for performing HIV testing for ANC during the 2012 HIV sentinel survey period 
2012- May 
a. a registered nurse 
D b. an enrolled nurse 
c. always a community counselor 
d. either an RN or an EN, on who is 
e. either an RN, an EN, or a community depending on who is available 
f. other 
14b. if specify _________ 
15. How many community ......" .... were .....'..'tnr ..... rapid at this facility during the 2012 NHSS survey 




D d. three or more 
16. If rapid 1"0.:1"."". is performed on where in the is the rapid to.~ti"I" performed? 
D a. in the ANC consultation room 
b. in a HIV counseling and or "rapid testing" room 
Dc. Not 
17. If rapid 1"0.:1-1"... is performed in a room within the where is room in relation to ANC 
consultation room? 
a. in same building as the ANC consultation within the same 
b. in a different building from the ANC consultation within the same facility 
Dc. Not 
18. If rapid testing is performed in a room, when is the woman tested during the ANC visit? 
D a. before the medical examination 
D b. after the medical examination 
Dc. Not a 
19. If rapid testing is performed in a separate room within the facility, on average, how must a woman usually 
wait in queue to be tested? 
D a. no waiting in a queue, women tested im 
b. < 10 minutes 
c. 10-15 minutes 
D d. 15-20 minutes 
e. >15 minutes 
f. Not 
20. If rapid testing is performed in a separate room within the facility, on average, how long must a woman usually 
wait in queue to return to the ANC consultation room after she finished rapid 
D a. Usually no in a queue, women tested immediately 
D b. < 10 minutes 
D c. 10-15 minutes 
d. 15-20 minutes 
e. >15 minutes 
f. Not 
2ia. Who records the HIV test in the HCT 
D a. always a nurse 
b. always an nurse 
c. always a community counselor 
D d. either an RN or an on who is available 
D e. either an RN, an or a community counselor depending on who is 
D f. other 
2ib. if /lather", 
for reu'nr"tin,a the of the HIV test in 
b. enrolled nurse 
c. community counselor 
d. either an RN or an on who is available 
e. either an RN, an EN, or a community counselor depending on who is available 
f. 
22b. if "other", 
22a. Who is "I!>c:nnnci 
a. nurse 
23a.lf testing is performed in a separate room, how is the result of the HIV test entered into the ANC 
then the ANC nurse enters the HIV result from the ANC 
passport into the ANC register when the woman returns to ANC consultation room (during the same visits) 
a. the rapid tester enters the HIV result into the ANC 
b. the rapid tester enters the HIV result into a hand-written note and gives the note to the When the client 
returns to the ANC consultation room, ANC nurse enters the result from the note into the woman's ANC 
and the ANC 
c. the rapid tester enters the HIV result into the ANC passport, and then the rapid tester enters all of the day's HIV 
results from the HCT into ANC register at the end of the 
d. the tester enters the HIV into the ANC passport, and the ANC nurse enters the day's HIV 
results from the HCT into the ANC at the end of the day 
De. other 
23b. If "other", please specify 
24a. In the facility's HCT are ANC and P"PlnPI"::! population clients included in the same register? 
o a. ANC clients and clients are entered in same HCT 
b. there are two separate HCT registers: one for ANC and one for general population clients 
24b. if "a. same register", does the facility use any code to ANC clients in the HCT ? (confirm by 
checking the register) 
a. Yes 
Db. No 
24c. If "yes", describe the code by the facility ___________ 







25b. If "yes" how many distinct instances of stock out were there in the 12 months? 
a. 	 one 
o b. two 
o c. 3 or more 
25c.lf how did women receive their HIV test theJ 
a. were ELISA 
b. 	 women were to return at a later date when test kits were to 

return in stock 

c. 	 women were not tested and were not instructed to return a test at a later date. 
26a. In your own words, please describe the term "known positive" and when it is appropriate to record "KP" in the 
ANC/PMTCT 
a. when the woman is tested during the current ANC visit, receives a test result and therefore knows that 
she is HIV 
b. the women has been tested for HIV and received a before presenting to the first AI\JC visit 




27a.lf a woman already knows she is HIV-positive upon nr~'.... ntllnu at her first ANC visit, and she has 
fffll"lJ/'l1P,ntr:ltUln af her status the ANC passport) is she still an HIV test for PMTCT? 
a. Yes 
Db. No 
27b. If No, what is recorded in the pregnant woman's "HIV test in the ANC Register 
a. 1/1" or "p" 
o b. "5" or "KP" 
Dc. recorded 
d. Other ___ 
27c. If "~.,..~,." specify __________ 
37 
28. If a pregnant woman already knows is HIV-positive upon at her first ANC visit} and she does not 
have documentation of her status (i.e. the ANC passport) is she still given an HIV test for PMTCT? 
a. Yes 
Db. No 
29. If are and sent to the lab for ELISA HIV testing} how are results to your facility? 
a. Returned by the lab to the ANC clinic of the health facility 
b. Returned by the site (lab, VCT etc.) to a department of the health facility other than ANC 
c. by the woman via the ANC passport 
30. When are the results of the laboratory ELISA HIV test results physically returned to this facility? 
o a. same day as testing 
b. <= 1 week after testing 
c. 1-2 weeks after 
d. > 2 weeks 
31a. When the results of the laboratory ELISA HIV test are returned to the facility, who is responsible for the 
results in the ANC register? 
a. nurse 
D b. enrolled nurse 
Dc. community counselor 
D d. other 
31b. if /lather", please specify ______ 
32a. During the last 12 months, did pregnant women have to pay for any part of ANC or PMTCT HIV testing services? 
D a. Yes 
b. No 

32b. If "yes" cost incurred for what? Specify ___________ 

38 
30a. Is syphilis testing part of routine ANC services the entire year? 
D a. Yes 
D b. No 
30b. If yes, where are specimens collected for syphilis testing at this facility? 
D a. in ANC consultation room 
b. in a separate room within this 
30c If in a separate room, specify ______ 
31. How are results of the syphilis test returned from the lab to the ANC dink? 
D a. Returned by the lab to the ANC clinic health 
b. Returned by site VCT site, to ANC clinic of the health facility 
c. Returned by the pregnant woman via the ANC passport 
32. When are the results of the syphilis test returned to the ANC clinic? 
D a. same day as 
D b. <= 1 week after 
c. 1-2 after 
d. > 2 weeks testing 
33a. Who is for entering the syphilis test results in ANC 
a. registered nurse 
Db. nurse 
c. community counselor 
D 	d. other 
33b. if other, specify ________ 
39 
34a. When are the results of the syphilis test to woman? 
o a. when the woman returns a follow-up visit 
b. when the woman returns for delivery 
Dc. other 
35b. if other, please specify _________ 
35a. If the woman does not return for a follow-up visit, how are the results of the syphilis test to her? 
a. attempt to contact woman by telephone 
b. staff attempt to contact the woman by community based 
o c. the results are not returned to the woman unless she returns for a follow-up visit. 
o d. other 

35b. if other, 

36. Who is currently responsible for completing the ANC/PMTCT monthly summary forms? 
o a. always a registered nurse 
o b. always an enrolled nurse 
o c. always a community counselor 
o d. an RN or an EN, on who is available 
o e. an RN, an EN, or a community counselor depending on who is available 
o f. other 
37. Who was responsible for completing the ANC/PMTCT monthly summary forms during the 2012 NHSS study period 
(Mar 2012 - May 2012? 
a. always a nurse 
:::J b. always an enrolled nurse 
c. always a community counselor 
d. either an RN or an EN, depending on who is available 
e. either an RN, an EN, or a community counselor depending on who is available 
f. other 
Assessment Form (Monthly Summary)D: Summary 
SUMMARY REPORTING ASSESSMENT (Monthly Summary FORM 





13-Mar :-Apr I 13-May 
I 
Women starting ANC ANC 01 i 
I I 
I 
ANC clients pre-test 
counseled ANC02 
ANC clients KNOWN HIV 
I 
I 
POSITIVE ANC 02.1 





ANC clients (tested) HIV 
positive ANC03 
• 




ANC clients positive but not I 
Iyet 14 weeks ANC09 
ANC clients ARV 
I 
I 
(prophylaxis) ANC 10+11 
ANC clients started on HAART I 
In ANC ANC 12 
ANC clients ANC 13 
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Appendix E: Summary Reporting Assessment (Register) Form 
SUMMARY REPORTING ASSESSMENT (REGISTER) FORM 
Facility Name NHSS Site Code (XXX-II) 
Indicator Month 
12-Mar 12-Apr 12-May 13-Mar 13-Apr 13-May 
Women starting ANC 
ANC clients pre-test counseled 
-­
ANC clients KNOWN HIV 
POSITIVE 
ANC clients tested for HIV 
ANC clients (tested) HIV 
positive 
ANC clients (tested) HIV 
negative 
ANC clients positive but not yet 
14 weeks 
ANC clients given ARV 
(prophylaxis) 
ANC clients started on HAART I 
in ANC 
ANC clients already on HAART 
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